financetom
Business
financetom
/
Business
/
Manulife profit rises on Asia business strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Manulife profit rises on Asia business strength
Nov 9, 2024 11:41 AM

Nov 6 (Reuters) - Manulife Financial ( MFC ) posted a

rise in third-quarter profit on Wednesday, as the Canadian

insurer benefited from a robust performance in its Asia

business.

The company's core earnings increased to C$1.83 billion

($1.31 billion), or C$1.00 per share, in the three months ended

Sept. 30, from C$1.74 billion, or 92 Canadian cents per share, a

year ago.

($1 = 1.3939 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cleveland-Cliffs Amends Asset-Based Lending Facility to Support Stelco Acquisition
Cleveland-Cliffs Amends Asset-Based Lending Facility to Support Stelco Acquisition
Sep 13, 2024
09:27 AM EDT, 09/13/2024 (MT Newswires) -- Cleveland-Cliffs ( CLF ) said Friday it amended its $4.75 billion asset-based lending facility to support its upcoming acquisition of Stelco Holdings, replacing Goldman Sachs ( GS ) with increased commitments from other banks including Bank of America ( BAC ) , Wells Fargo ( WFC ) and JP Morgan (JPM). Banks such...
Graham Holdings Board Authorizes Repurchase of Up to 500,000 Class B Shares
Graham Holdings Board Authorizes Repurchase of Up to 500,000 Class B Shares
Sep 13, 2024
09:25 AM EDT, 09/13/2024 (MT Newswires) -- Graham Holdings Company ( GHC ) said Friday that its board has approved the repurchase of up to 500,000 shares of its class B common stock. The company did not set a maximum purchase price or a deadline for the buyback. Price: 754.00, Change: +6.25, Percent Change: +0.84 ...
Ascendis Says Initial Data Shows Anti-Tumor Activity in Phase 1/2 Platinum-Resistant Ovarian Cancer Trial
Ascendis Says Initial Data Shows Anti-Tumor Activity in Phase 1/2 Platinum-Resistant Ovarian Cancer Trial
Sep 13, 2024
09:25 AM EDT, 09/13/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Friday that initial results from a certain group of patients with platinum-resistant ovarian cancer showed signs of clinical activity in a phase 1/2 trial of the TransCon IL-2 beta/gamma drug in combination with chemotherapy. Anti-tumor clinical responses were observed in 29% of the 18 patients in a...
CSG raises cash component of its bid for Vista Outdoor's arms unit
CSG raises cash component of its bid for Vista Outdoor's arms unit
Sep 13, 2024
Sept 13 (Reuters) - Vista Outdoor ( VSTO ) said on Friday Czechoslovak Group (CSG) has increased the cash component of its offer to buy the company's arms business, Kinetic Group, by $4 a share and would also purchase 7.5% of its Revelyst unit for $150 million. The proposed share purchase would value Revelyst, Vista's outdoor sporting gear business, at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved